학술논문
1203O FOLFOX plus nivolumab and ipilimumab versus FOLFOX induction followed by nivolumab and ipilimumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Results from the randomized phase II Moonlight trial of the AIO
Document Type
Abstract
Author
Source
In Annals of Oncology September 2022 33 Supplement 7:S1099-S1099
Subject
Language
ISSN
0923-7534